Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

humacao_exterior

BMS agrees deal on Opdivo availability through Cancer Drugs Fund for head and neck cancer

October 13, 2017 Sales and Marketing BMS, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, NICE, opdivo, pharma, pharmaceutical

Thanks to successful negotiation of a managed access agreement, NICE has announced its recommendation of Bristol-Myers Squibb’s Opdivo (nivolumab) for …
News
news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
News
fda2outsideweb

Aerie’s glaucoma drug gets strong preliminary FDA opinion

October 12, 2017 Sales and Marketing Aerie, Aerie Pharmaceutical, FDA, Glaucoma, Rhopressa, pharma

In a preliminary review of the drug, the FDA has judged that Aerie Pharmaceutical’s experimental glaucoma treatment Rhopressa (netarsudil) effectively …
News

NICE gives final draft guidance on two key cancer drugs

October 12, 2017 Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga

NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …
News
merckwindowweb

MSD gives up on cholesterol drug, despite positive results

October 12, 2017 Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …
News
shutterstock_254160583

Lupin scoops up women’s health specialist Symbiomix for $150 million

October 11, 2017 Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
News
biocon-ltd-hebbagodi-bangalore-ukif4_web

Mylan and Biocon Neulasta biosimilar knocked back by FDA

October 11, 2017 Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
News
allergan

Allergan settles gender discrimination case for $4m

October 11, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
News
david-crossman300_web

NHS Scotland appoints new Chief Scientist

October 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …
Appointment
california-2798001_960_720

California signs into law transparency over drug pricing

October 10, 2017 Manufacturing and Production, Sales and Marketing Drug pricing, biotech, california, drugs, pharma, pharmaceutical

In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …
News
shutterstock_360472550

Harnessing the power of the immune system

October 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
Feature
roche_close

Roche’s 99% accurate Zika test receives FDA approval

October 9, 2017 Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical

Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …
News
astrazeneca-sign

AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC

October 9, 2017 Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer

AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …
News
contraceptive-pills-849413_960_720

Trump sweeps away birth control coverage

October 9, 2017 Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical

Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …
News
800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017 Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026